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Abstract 
 
 
Human Papillomavirus (HPV), the most common sexually transmitted infection 
(STI) in the United States, is responsible for many types of cancer that affect both sexes. 
Though vaccines to protect against HPV have existed since 2006, they are still 
underutilized, leaving college students at risk of HPV infection. In order to address low 
vaccination rates with a strategic message, we must first understand individual-level 
factors associated with intention to get vaccinated. A Reasoned Action approach is used 
to identify attitudinal, normative, and control factors, and their underlying beliefs, 
associated with vaccination intention. 
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Introduction 
Human Papillomavirus (HPV) is a sexually transmitted infection (STI) that causes 
a number of health issues, such as genital warts and several types of cancer. HPV is 
preventable and two vaccines exist to protect against it. The quadrivalent vaccine, 
Gardasil®, protects against oncogenic HPV types 16 and 18 and nononcogenic types 6 
and 11 (CDC, 2010a). The bivalent vaccine, Cervarix®, protects against oncogenic HPV 
types 16 and 18 (CDC, 2010a). According to the CDC, both vaccines have high efficacy 
against cervical precancer lesions associated with HPV types 16 and 18. In addition, the 
quadrivalent vaccine has high efficacy against genital warts associated with HPV types 6 
and 11 and vaginal and vulvar precancer lesions associated with HPV types 16 and 18 
(CDC, 2010a). Though both vaccines are licensed for use in females ages 9 through 26 
years, and the quadrivalent vaccine is licensed for use in males ages 9 through 26 years 
(CDC, 2010b), national vaccination rates remain low (CDC, 2013a). Vaccination rates 
are particularly low among males and those identifying as LGBT (McRee et al., 2014; 
CDC 2013a). Therefore, HPV continues to be an important public health issue in the 
United States.  
Because HPV is still an important public health issue and the vaccines to protect 
against it are a relatively new phenomenon, HPV has received a significant amount of 
media coverage in the last six years. News coverage of HPV and cervical cancer spiked 
in May, June, and July of 2006, just prior to and directly following the FDA approval of 
the vaccine (Kelly et al., 2009). A majority of the news coverage during this time was 
print news, with very few stories on HPV and cervical cancer found in broadcast news 
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(Kelly et al., 2009). A majority of news headlines framed HPV vaccination as a cancer 
prevention issue (as opposed to an STI prevention issue)—consistent with how Merck’s 
Gardasil vaccine was marketed (Rothman & Rothman, 2009)—but the stories themselves 
were often missing key details, such as the need for continuing cervical cancer screening 
after completing the vaccination series (Kelly et al., 2009). Using a nationally 
representative sample of adults and a longitudinal survey, the authors found HPV 
knowledge was significantly associated with exposure to health-related news content in 
the six months following FDA approval of the vaccine (Kelly et al., 2009).    
Research has shown that in addition to the amount of coverage being an important 
factor in promoting vaccine knowledge, the way HPV vaccination is framed in the media 
matters because framing can influence public opinion, policy support, and vaccination 
intention. Studies have shown that when media present HPV vaccination mandates for 
school children as a controversial subject, support for mandatory HPV vaccination wanes 
(Fowler & Gollust, 2015; Gollust et al., 2010). On the other hand, positively-framed HPV 
vaccination messages (e.g., vaccine is 70% effective) has been associated with more 
support for vaccine mandates and higher vaccine effectiveness ratings than negatively-
framed but logically equivalent HPV vaccination messages (e.g., vaccine is 30% 
ineffective) (Bigman, Cappella, & Hornik, 2010). In addition, politicization of HPV 
vaccination has been found to negatively influence support for national and state 
vaccination mandates and trust in doctors and government (Fowler & Gollust, 2015). As 
mentioned above, a majority of the HPV news coverage in 2006 used a cancer prevention 
frame (Kelly et al., 2009), which has been found to increase women’s intentions to 
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vaccinate themselves (Leader et al., 2009). Thus while it is possible that media coverage 
and framing of HPV has influenced vaccine uptake, this study focuses on individual-level 
factors that influence vaccination decisions, which may or may not be derived from 
media exposure.  
Attitudes, perceived norms, perceived behavioral control, and their underlying 
beliefs are individual-level cognitive factors that can affect health behaviors (Fishbein & 
Ajzen, 2010), though we know little about the beliefs that could influence HPV 
vaccination uptake among college students. Informed by the Reasoned Action approach 
(Fishbein & Ajzen, 2010), the goal of this study is to identify salient beliefs about HPV 
vaccination and, ultimately, inform the design of pro-vaccination messages for use in a 
college setting. By targeting beliefs most relevant to the college student population, 
future research can create more persuasive strategic messages that will hopefully increase 
vaccine uptake in this undervaccinated catch-up population.   
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Literature Review 
Topics discussed in the literature review include the epidemiologic data on the 
population burden of HPV, what is known about HPV vaccination among college 
students, previously identified belief correlates of HPV vaccination, the disparities in 
HPV vaccination among male and LGBT populations, and HPV vaccination’s 
relationship to individuals’ religiosity. 
Population burden of HPV 
According to the Centers for Disease Control and Prevention, the Human 
Papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the 
United States, with 79 million current infections nationwide (CDC, 2014). Of the more 
than 100 types of the virus, 40 are sexually transmitted, and 16 are known to be high-risk, 
or oncogenic (CDC, 2012). The oncogenic types are associated with cancers of the 
cervix, vulva, vagina, penis, anus, throat, tongue, and tonsils (CDC, 2012). The 
association between HPV and anogenital cancers is well established and studies support 
its role in oropharyngeal cancers as well.  
Between 2000 and 2009, incidence rates of HPV-related cancers that affect U.S. 
men, including cancer of the oropharynx and anus, increased (Jemal et al., 2013). 
Oropharyngeal cancer is the most prevalent HPV-related cancer in men, accounting for 
78.2% of HPV-related cancer cases, and in 2009, anal and oropharyngeal cancers 
accounted for a combined 92.6% of HPV-associated cancers in men (Jemal et al., 2013).  
  According to the CDC, 99% of cervical cancers contain at least one of the high-
risk types of HPV, with types 16 and 18 accounting for about 70% of all cervical cancers 
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(CDC, 2012). In addition, HPV types 16 and 18 have been found in around 90% of HPV-
related non-cervical cancers (Gillison, Chaturvedi, & Lowy, 2008). Because the HPV–
cervical cancer link has been so well established over the past 20 years, prevention efforts 
have largely ignored its link to other cancers that affect both sexes.  
The bivalent HPV vaccine (Cervarix®) protects against high-risk HPV types 16 
and 18, but it was not until 2009 that the U.S. Food and Drug Administration approved 
the quadrivalent HPV (Gardasil®) vaccine for use in boys and men ages 9 through 26 
(CDC, 2010b; Sun, 2009). In the U.S., most new cases of HPV are diagnosed in youth 
ages 15 to 24 and catch-up vaccinations are recommended through age 26 (CDC, 2013b). 
Despite these recommendations, only 37.6% of girls and 13.9% of boys ages 13 to 17 
received all three doses of the HPV vaccine in 2013 (CDC, 2013a). In addition, LGBT 
status has been correlated with HPV-related knowledge gaps, higher burden of HPV-
related infections and cancers, and lower vaccination rates (McRee et al., 2014; Nyitray 
et al., 2011; Polek & Hardie, 2010). According to McRee et al. (2014) the HPV 
vaccination completion rate among a national sample of college-age bisexual and lesbian 
women was only 32%. Therefore, college-aged men and women, especially those 
identifying as LGBT, are still at risk for HPV infection. 
Because HPV infection continues to be a problem among young men and women, 
the incidence of HPV-related cancers continues to increase in men, and vaccination rates 
continue to be low (particularly in the male and LGBT populations), it is important to 
understand the factors that influence young men’s and women’s HPV vaccination 
decisions. Understanding why vaccination rates remain low across the board and why 
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vaccination disparities exist is a necessary first step for designing effective HPV 
communication interventions. 
HPV vaccination among college students 
Since the HPV vaccine’s1 introduction in the United States in 2006, researchers 
have been interested in both distal and proximal variables associated with vaccine uptake 
(CDC, 2011). Because the vaccine was not approved for adolescent boys and young men 
until 2009, 
HPV vaccination research has predominantly focused on adolescent females (Bryer, 
2014; Herbert, 2014; Reiter, Katz, & Paskett, 2013; Hollander, 2010; Gerend, Wibley, & 
Bland, 2009; Reiter et al., 2009; Dempsey et al., 2006).    
Though a body of literature exists on HPV vaccinations in adolescent (primary) 
populations, less is known about HPV vaccinations in college student (catch-up) 
populations. The adolescent-focused literature is abundant because the CDC recommends 
vaccination for youth prior to sexual debut, specifying ages 11 and 12 as ideal for 
vaccination (CDC, 2015). Due to ethical and legal constraints, most adolescent research 
is conducted with parents of adolescents and not the adolescents themselves. A multitude 
of studies have thus examined HPV vaccine acceptability among parents of youth under 
age 18 (Bryer, 2014; Herbert, 2014; Reiter, Katz, & Paskett, 2013; Garcini, Galvan, & 
Barnack-Tavlaris, 2012; Hollander, 2010; Gerend, Wibley, & Bland, 2009; Reiter et al., 
2009; Dempsey et al., 2006). Because the vaccine was approved in the U.S. only 9 years 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 There are two distinct bodies of literature on HPV: disease-focused and vaccine-focused. An abundance of the 
disease-focused literature, unsurprisingly, came about prior to the introduction of the vaccine. Because the aim of this 
study is to inform pro-vaccination messages, the vaccine literature is the focus of this review.   
	   	   	  	  
	  
7
ago and has been slow to catch on, overall vaccination rates among youth remain low. 
According to Stokley et al. (2014), only 5.9% of adolescent girls had completed all three 
doses of the vaccine by 2007. By 2013, only 37.6% of adolescent girls and 13.9% of 
adolescent boys ages 13 to 17 were fully vaccinated (Stokey et al., 2014). Those who 
were aged 11 to 12 in 2006 would now be college students, and, given their low 
vaccination rates up to age 17, would still be at risk for contracting HPV.  
Belief correlates of HPV vaccination 
There has been limited research regarding individual-level cognitive factors that 
influence HPV vaccination decision-making among college students. Sociodemographic 
correlates of vaccination initiation and completion have received a majority of the 
attention, while less attention has been paid to correlates such as attitudes and their 
underlying beliefs. In line with epidemiologic methods and Health Belief Model 
frameworks, research has looked at correlates such as sexual activity, HPV knowledge, 
and perceived risk. Between 1995 and 2007 (the pre-approval vaccine testing period), 28 
U.S.-based studies that examined HPV or HPV vaccine-related awareness, knowledge, or 
attitudes were identified (Brewer & Fazekas, 2007). Of the studies that included vaccine 
acceptability measures among “adolescents, young adults, and parents of adolescents,” 
only 13 focused on vaccine-related awareness, knowledge, or attitudes, and of those, only 
one focused on college students (Brewer & Fazekas, 2007, p. 108). 
Some studies on college students have identified beliefs correlated with HPV 
vaccination intention and behavior, but few of them have been qualitative and their 
samples have not been congruent. The most common sample type was female-only 
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(Krakow et al., 2014; Lipschitz et al., 2013; Hopfer and Clippard, 2011), and often 
included particular segments of the female college student population such as American 
Indians (Hodge et al., 2011) or Latinas (Schiffner and Buki, 2006). Also, though beliefs 
did arise in the literature, they were not necessarily referred to as beliefs nor were they 
identified using a belief elicitation approach – discussed in-depth below in the 
Theoretical Framework section. According to Fishbein and Ajzen (2010), qualitative 
belief elicitation research is important because in order “to understand why people hold 
certain attitudes at a given point in time, it is necessary to assess their readily accessible 
beliefs” about HPV vaccination (p. 100).   
Identified beliefs regarding HPV vaccination among college students included 
feelings of security and protection from HPV (Dillard, 2011), fear of vaccine side effects 
(Hodge et al., 2011), desire to prevent cancer (Hopfer and Clippard, 2011), and not 
having to worry about HPV anymore (Mehta et al., 2013). In addition, having parental 
(Bendik, Mayo, & Parker, 2011; Hodge et al., 2011), family (Hopfer and Clippard, 2011; 
Schiffner and Buki, 2006), peer/friend (Bendik, Mayo, & Parker, 2011; Dillard, 2011; 
Hopfer and Clippard, 2011; Martin et al., 2011; Schiffner and Buki, 2006), partner 
(Bendik, Mayo, & Parker, 2011; Dillard, 2011), and healthcare provider support (Hopfer 
and Clippard, 2011) was often deemed important when considering vaccination. Many 
students felt that HPV vaccination was socially acceptable and normalized in their social 
circles (Krakow et al., 2014; Hodge et al., 2011; Hopfer and Clippard, 2011). The degree 
to which students felt that the vaccine was socially acceptable and that the 
aforementioned people supported HPV vaccination influenced their decisions to get 
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vaccinated. Knowing someone who had already been vaccinated and having a healthcare 
provider recommend the vaccine were predictive of already having been vaccinated 
(Daley et al., 2010).  
Barriers to HPV vaccination among college students included cost/health 
insurance (Mehta et al., 2013; Dillard, 2011; Hodge et al., 2011; Dillard & Spear, 2010), 
lack of vaccine information and knowledge (Mehta et al., 2013; Hodge et al., 2011; 
Dillard & Spear, 2010), vaccine mistrust and fear of side effects (Mehta et al., 2013; 
Hopfer and Clippard, 2011; Martin et al., 2011; Dillard & Spear, 2010), time constraints 
(Hopfer and Clippard, 2011), and vaccine availability (Mehta et al., 2013; Hopfer and 
Clippard, 2011).  
HPV vaccination among male and LGBT populations  
Studies attempting to examine male or LGBT college student populations are 
somewhat scarce. Only a few studies have attempted to examine correlates of vaccination 
among male college student populations (Fontenot et al., 2014; Crosby et al., 2012) and 
some have compared male and female college student populations (Beshers et al., 2014; 
Ramirez-Rios & Bonnez, 2014; Patel et al., 2013; Bynum et al., 2011; Sandfort & 
Pleasant, 2009). Additionally, LGBT status has only recently become a variable of 
interest in the prediction of HPV vaccination, though research suggests it could be an 
important factor (McRee et al., 2014; Zou et al., 2014; Francis, Highland, & Thorpe, 
2012; Polek & Hardie, 2010). The LGBT population shoulders a higher burden of HPV-
related disease than the heterosexual population. Men who have sex with men are more 
	   	   	  	  
	  
10
likely to contract anal HPV (CDC, 2014b) and are at a greater risk for anal cancer 
(Brewer, 2010).  
HPV vaccination and religiosity  
In addition, studies have shown that religiosity is correlated not only with sexual 
behavior, but also with HPV vaccination behaviors as well (Lefkowitz, Gillen, Shearer, & 
Boone, 2004; Hardy & Raffaelli, 2003; Meier, 2003; Nonnemaker, McNeely, & Blum, 
2003; Krakow et al., 2014; Barnack, Reddy, & Swain, 2010; Constantine & Jerman, 
2007). Formative research on adolescents suggests religiosity is associated with 
abstinence, delayed sexual intercourse, and fewer partners (Lefkowitz, Gillen, Shearer, & 
Boone, 2004; Hardy & Raffaelli, 2003; Meier, 2003; Nonnemaker, McNeely, & Blum, 
2003). More recent research on college students found spirituality, fundamentalism, and 
intrinsic religiosity were negatively correlated with almost all types of measured sexual 
behaviors among college students (Farmer, Trapnell, & Meston, 2009). Fundamentalism, 
in particular, was correlated with less sexual activity among women (Farmer, Trapnell, & 
Meston, 2009).    
Christian parents (other, born-again, and evangelical) and those who attend 
religious services more than once a week are among the subgroups less likely to endorse 
HPV vaccination for their children (Constantine & Jerman, 2007). In contrast, parents 
who report rarely or never attending religious services comprise one of the subgroups 
most likely to endorse vaccination for their children (Barnack, Reddy, & Swain, 2010). In 
a study among undergraduate women, Krakow et al. (2014) found religiosity was 
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negatively correlated with HPV vaccination intention; that is, those who scored higher on 
the religiosity scale were less likely to intend to vaccinate.  
 
Summary 
As discussed above, HPV is the most common STI in the United States, and some 
strains are known to cause cancers that affect both men and women. Though two 
vaccines exist to protect against the two strains that cause most HPV-related cancers, they 
are still underutilized, leaving college students in the catch-up vaccination age range still 
at risk. So far, we know that college students want to feel protected against HPV, that 
their social networks have important influence when it comes to vaccination decisions, 
and that there are a number of barriers to vaccination like cost and time. Yet there is a 
need for more systematic, theory-based, population-specific research to identify salient 
beliefs and, in turn, promote vaccination among college-age men and women. Previous 
research has also highlighted the HPV risk and vaccination disparities among male and 
LGBT populations, as well as the relationship between one’s level of religiosity and 
sexual and HPV vaccination behaviors. Therefore, vaccination beliefs in these specific 
catch-up populations deserve further study. 
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Theoretical Framework: Reasoned Action 
To best understand the relationship between HPV vaccination beliefs, attitudes, 
subjective norms, perceived behavioral control, and intentions, a Reasoned Action 
approach will be used to inform the measures and analysis.  A Reasoned Action approach 
(Fishbein &Ajzen, 2010) is one of the only theories that contends “that there are only a 
limited number of variables that need to be considered in predicting and understanding 
any given behavior” (Fishbein & Yzer, 2003, p. 165). According to Fishbein and Yzer 
(2003), this approach “represents the more conventional view that changing beliefs 
underlying the intention to perform a behavior ultimately results in changes in intention” 
(p. 164). Further, “performance of a given behavior is primarily determined by the 
strength of a person’s intention to perform” it (Fishbein & Yzer, 2003, p. 165). Due to the 
inconsistent research findings on the role of perceived risk, theories such as the Health 
Belief Model that contain perceived risk as a proximal determinant of intention and 
health behavior will not be used (Fishbein & Yzer, 2003; Baume, 2000).  
The usefulness of the Reasoned Action approach lies in its ability to help identify 
which beliefs (behavioral, normative, or control) are most salient to behavior change, and 
thus which beliefs to target in a pro-HPV-vaccination campaign. Using this theoretical 
framework to guide my study will allow me to build upon the aforementioned literature 
in several ways. First, beliefs relevant to the college student population will be identified 
and analyzed qualitatively. This is important because this essential but often skipped step 
allows the population of interest to dictate their own salient beliefs instead of the 
researcher. Second, beliefs salient to all relevant college student subpopulations, such as 
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men, women, and those who identify as LGBT, will be generated and included in 
analysis. And finally, the theory guides analysis so I may identify which beliefs are most 
strongly correlated with intentions to get vaccinated against HPV.   The first step in 
creating an effective health message is to identify the key determinants that will need to 
be addressed in a campaign to move behavior. The second step is to look at the beliefs 
that underlie the key determinants identified in the analysis. The Reasoned Action 
approach will be used to identify the key determinants of HPV vaccination among 
college-age men and women.    
The Reasoned Action approach (Fishbein & Ajzen, 2010) follows the Integrative 
Model of Behavioral Prediction and is based on the Theory of Reasoned Action (Fishbein 
& Ajzen, 1975) and the Theory of Planned Behavior (Ajzen, 1985). The model integrates 
the constructs of beliefs, attitudes, and intentions from the former and perceived 
behavioral control from the latter, as well as barriers to behavior. Together, these 
constructs predict and account for “a substantial proportion of the variance in any 
behavior in any population” (Yzer, 2012a, p. 22). The most current iteration of the theory 
is interchangeably referred to as the Theory of Reasoned Action or the Reasoned Action 
approach in behavior change literature. To stay consistent with the authors of this theory, 
I will refer to the theory as the Reasoned Action approach (Fishbein & Ajzen, 2010).  
Intention 
According to the Reasoned Action approach, intention is the most proximal 
determinant of behavior and is a function of attitude, perceived norm, and perceived 
behavioral control. Because “intentions are assumed to capture the motivational factors 
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that influence behavior,” it follows that the stronger the intention is, the more likely one 
is to perform the behavior (Ajzen, 1991, p. 181). Thus, intention is measured as a 
probability of how likely one is to perform the recommended behavior, i.e. getting an 
HPV vaccination. Intentions are strong predictors of behavior in the presence of personal 
ability and the absence of environmental constraints.    
Attitude toward behavior 
The theory proposes that attitudes result automatically from a person’s behavioral 
beliefs. As explained by the Expectancy-Value Model, attitudes are the sum of the 
strength of beliefs that an object has a certain attribute multiplied by the evaluation of 
that attribute (Fishbein and Ajzen, 2010). It follows, then, that favorable attitudes are 
generated when objects are associated with positively evaluated attributes and negative 
attitudes are generated when objects are associated with negatively evaluated attributes. 
As discussed below, attitude formation relies on salient beliefs.  
Instrumental vs. Experiential Aspects. 
Attitudes, like subjective norms and perceived behavioral control, are two-
dimensional. The instrumental dimension refers to the cognitive aspect of attitude and the 
experiential dimension refers to the affective aspect of attitude. According to Fishbein 
and Ajzen (2010), “cognitive aspects of attitude involve such dimensions as wise—foolish 
and harmful—beneficial” and affective aspects involve “such “dimensions as pleasant—
unpleasant and boring—interesting” (p. 82).  
Subjective norm 
Subjective or perceived norm refers to the normative social pressure surrounding 
	   	   	  	  
	  
15
the recommended behavior. According to the theory, perceived norm has two aspects, 
namely injunctive and descriptive norms.  
Injunctive vs. Descriptive Norms. 
 Injunctive norms refer to what one perceives should or ought to be done with 
regard to the behavior in question; that is, how supportive one feels their important social 
networks would be of them performing the recommended behavior (Ajzen, 1991). 
Alternately, descriptive norms refer to the actual performance of the behavior within 
one’s important social networks.; that is one’s perception as to whether or not others are 
performing the behavior in question (Fishbein & Ajzen, 2010). Although the original 
Theory of Reasoned Action used the term “subjective norm” to mean injunctive norms 
exclusively, the current iteration of the Reasoned Action approach used here defines 
subjective norms as integrating “both the desires [injunctive aspect] and the actions 
[descriptive aspect] of important referent individuals and groups” (Fishbein & Ajzen, 
2010, p. 131).  
Perceived behavioral control 
Perceived behavioral control, in the latest iteration of the Reasoned Action 
approach, is defined as “people’s perception of the degree to which they are capable of, 
or have control over, performing a given behavior” (Fishbein & Ajzen, 2010, p. 64). 
Citing Bandura (1977, 1986, 1997), Yzer (2012c) asserts the constructs of perceived 
behavioral control and self-efficacy are conceptually the same. Perceived behavioral 
control, however, has two dimensions: capacity and autonomy. According to the theory, 
the more one believes they can successfully and autonomously perform the recommended 
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behavior, the more likely they are to perform it (Yzer, 2012).       
Capacity vs. Autonomy.  
Capacity refers to one’s belief that they have the capacity, or the skills necessary 
and ability to perform the recommended behavior. The capacity dimension of perceived 
behavioral control is captured asking participants how sure they are that they can get at 
least one HPV vaccination in the next twelve months in the face of obstacles, such as lack 
of time or health insurance. Autonomy refers to one’s belief that they have control over 
their performance of the recommended behavior (Fishbein & Ajzen, 2010; Yzer, 2012c). 
The autonomy dimension of perceived behavioral control is captured using statements 
like: “getting at least one HPV vaccination in the next twelve months is: up to me—not 
up to me.” 
Beliefs 
The Reasoned Action approach proposes that beliefs underlie attitudes, subjective 
norms, and perceived behavioral control, which in turn influence intentions to perform a 
given health behavior (Fishbein & Yzer, 2003).  
According to Fishbein and Ajzen (2010) and Yzer (2012b), beliefs are central 
constructs to the explanation of behavior. The term “reasoned” in the theory comes from 
the expectation that there is a rational process behind acting on beliefs about a particular 
behavior. For example, one might get an HPV vaccination if they believe it will truly 
protect them against contracting HPV. Beliefs serve as the “cognitive basis” for reasoned 
behavior (Yzer, 2012b, p. 121). 
Beliefs are central to the theory because they inform everything in the model that 
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follows, including attitudes, perceived norms, perceived behavioral control, and 
ultimately intentions. According to the theory, behavior cannot be directly influenced, but 
beliefs can. This is important because, following the flow of the model, influencing 
beliefs can directly influence attitudes, perceived norms, and perceived control, which 
can influence intention and ultimately behavior. The goal of this study is to identify the 
proximal determinants (attitudes, subjective norms, or perceived behavioral control) in 
the target population that are most strongly associated with intention to get an HPV 
vaccination. This is important because influencing the beliefs that underlie these proximal 
determinants could lead to the greatest magnitude of behavior change (to get the HPV 
vaccination if they have not) or reinforcement (to finish getting all three vaccinations if 
they have already gotten one or two).   
According to the theory, the three types of beliefs that influence attitudes toward 
the behavior, perceived norms, and perceived behavioral control are behavioral, 
normative, and control beliefs, respectively.  
Behavioral beliefs. Behavioral beliefs are the beliefs one has about the outcomes 
of the recommended behavior and his or her evaluations of these beliefs. These beliefs 
are defined as “the subjective probability that an object has a certain attribute” and 
represent the information a person has about an object, in this case, the HPV vaccine 
(Fishbein & Ajzen, 2010, p. 96; 1975). This information, aka beliefs, forms the basis of 
an attitude . Behavioral beliefs yield negative or positive attitudes toward the 
recommended behavior (Ajzen, 1991). For example, one might believe that getting an 
HPV vaccination (the object) will protect them against HPV infection in the future (the 
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attribute).  
Normative beliefs. Normative beliefs are the beliefs one has about others’ 
expectations and how motivated they are to comply with these normative expectations. 
Normative beliefs produce perceived social norms or pressure (Ajzen, 2006).  
Control beliefs. Control beliefs are beliefs one has about what may help or hinder 
his or her efforts to perform the recommended behavior and how much power these 
factors have. Control beliefs yield perceived behavioral control, or the perception of how 
much control one has over performing the recommended behavior (Ajzen, 1991).    
According to Fishbein and Ajzen (2010), a person holds many beliefs, but only a 
few are relevant to attitude formation at any given time. The few that are relevant, termed 
salient beliefs, are the ones that are easily cognitively accessible and “serve as the 
prevailing determinants of the attitude” (Fishbein & Ajzen, 2010). Elicitation research 
allows us to get salient beliefs directly from our target audience through a qualitative 
survey. This first step allows us to ask the following question: 
RQ1: Which behavioral, normative, and control beliefs regarding HPV 
vaccination are most salient within the college student population? 
In addition to measuring the beliefs that underlie attitudes, subjective norms, and 
perceived behavioral control, we also measure these proximal determinants directly. 
Correlating each overarching construct with intention will allow us to determine which 
one matters the most in terms of getting at least one HPV vaccination in the next twelve 
months. Thus, we must ask the following question:    
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RQ2: Are attitudes toward vaccination, subjective norms regarding vaccination, 
or perceived behavioral control regarding vaccination most strongly associated 
with intention to get vaccinated against HPV? 
 
Building on Reasoned Action: the Hornik and Woolf Approach 
 Extending the Reasoned Action approach involves identifying promising message 
by determining which beliefs are most strongly correlated with vaccination intention, 
which of these beliefs is most moveable, and whether or not these beliefs could be 
influenced by a strategic message (Hornik & Woolf, 1999). Using beliefs as a central 
concept, Hornik and Woolf (1999) extend the Reasoned Action approach by mapping out 
a two-stage plan for identifying promising message strategies. The first stage involves 
cross-sectional survey design, which begins with “hypotheses about factors that might 
explain the behavior” (Hornik & Woolf, 1999, p. 35). Hypothesis generation, according 
to the authors, can be based on “available theory, on the best advice of informants, on 
discussions with groups representing the target audience, or on their [the researcher’s] 
own judgment” (p. 35). This study will draw on the qualitative belief elicitation survey of 
the target audience to generate hypotheses. Once these salient beliefs have been 
identified, we will ask the following question:  
RQ3: Which salient beliefs (behavioral, normative, or control) are most strongly 
associated with intention to get the HPV vaccination? 
The second stage involves analysis of the quantitative reasoned action survey, 
which will inform message strategy recommendations. The Hornik and Woolf (1999) 
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extension of the Reasoned Action approach is important because although a proximal 
determinant may not be highly correlated with intention, some or all of its underlying 
beliefs could be. When designing effective pro-vaccination messages it is important to 
consider all potential predictors of intention, as beliefs are what one targets in campaigns. 
To identify promising message strategies we must determine which beliefs are most 
likely to be affected by a strategic message: 
RQ4: Which intention-correlated beliefs are most likely to be affected by a 
strategic pro-vaccination message?  
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The Current Study 
Data analysis took part in two phases: 1) belief elicitation survey data analysis 
(RQ1), and 2) reasoned action survey analysis (RQ2). The first phase consisted of a 
qualitative, hand-coding analysis. Once the first phase was complete, the most salient 
beliefs culled from the belief elicitation data analysis were added to the reasoned action 
survey to form the closed-ended belief questions. The second phase consisted of 
software-assisted quantitative data analysis (correlations and regressions) and one sub-
analysis by gender. This two-phase approach has been applied in recent research (e.g., 
Yzer et al., 2015). Identification of promising message strategies for promoting HPV 
vaccination among college students will be addressed in the Conclusion and Further 
Research section (RQ3 and RQ4); for the purposes of this thesis, only select preliminary 
analyses have been completed, but all data have been collected to enable future study. 
 
Study 1: Belief Elicitation Survey 
 Phase one of our analysis examines the belief elicitation survey meant to glean 
salient beliefs about HPV vaccination from our college student sample to help us answer 
RQ1. 
Methods 
 A qualitative, open-ended belief elicitation survey was developed in accordance 
with Fishbein and Ajzen (2010) (Appendix A). The 14-item survey consisted of four 
demographic questions (sex, age, race, and LGBT identification), a religiosity scale, an 
eligibility question (number of lifetime HPV vaccinations received), and eight belief 
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elicitation questions. To be eligible, participants could not have had more than two 
lifetime HPV vaccinations and had to be age 18 through 26.  
 Participants and Procedure. The University of Minnesota’s School of Journalism 
and Mass Communication’s Research Subject Pool was used to recruit participants. The 
SJMC’s Research Division and the University’s Human Subjects Committee jointly 
maintain the Subject Pool. The Subject Pool runs throughout the academic year using 
students enrolled in journalism classes. All students enrolled in any of the SJMC’s classes 
are eligible for participation in the subject pool. Once they sign up for the Subject Pool, 
students receive emails alerting them of available studies for which they can sign up to 
participate. For their participation in each study, students receive finite extra credit points 
in their specified SJMC course.  
Institutional Review Board approval for this study was received on Monday, April 
13th, 2015 and data were collected from participants (N = 58) between April 15th and 
April 19th, 2015. After excluding a participant who did not answer any questions beyond 
age (n = 1), participants who were older than 26 years of age (n = 3), and participants 
who had already received all three HPV vaccinations in their lifetime (n = 22), the 
analytic sample contained data from 32 unique, qualified participants.  
 Measures. Once participants consented to participate in the survey, we first 
defined HPV and then outlined the CDC’s vaccination recommendations for men and 
women through age 26 (see Appendix A). Next, we asked a set of demographic 
questions: “What is your age?” (text box), “What is your sex?” (male/female), “Which of 
these groups best describes your racial or ethnic background?” (Latino/Hispanic, 
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Black/African American, Asian/Asian American, White/Caucasian, Native American, 
Other), and “Do you identify as LGBT?” (yes/no). To assess religiosity, we used the 
Abbreviated Santa Clara Strength of Religious Faith Questionnaire (Plante, Vallaeys, 
Sherman, & Wallston, 2002), which contains the following items on a four-point Likert 
scale (1 = strongly disagree; 4 = strongly agree): “I pray daily”, “I look to my faith as 
providing meaning and purpose in my life”, “I consider myself active in my faith or 
church”, “I enjoy being around others who share my faith”, and “My faith impacts many 
of my decisions.”  
Following the religiosity scale, we asked participants how many HPV 
vaccinations they had gotten in their lifetimes and a series of open-ended HPV 
vaccination-related questions. In addition to the age question above, question: “How 
many HPV vaccinations have you gotten in your lifetime?” was used to determine 
participant eligibility. Those whose responses to the vaccination eligibility question were 
0, 1, 2, or “I don’t know” were included in the analytic sample.  
To elicit behavioral beliefs, we asked several open-ended questions: “What do 
you see as the advantages of you getting at least one HPV vaccination in the next 12 
months? What are the good things that might happen if you would get at least one HPV 
vaccination in the next 12 months?” and “What do you see as the disadvantages of you 
getting at least one HPV vaccination in the next 12 months? What are the bad things that 
might happen if you would get at least one HPV vaccination in the next 12 months?” To 
elicit normative beliefs, we asked participants to: “Please list all the individuals or groups 
who would approve or think that you should get at least one HPV vaccination in the next 
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12 months” and “Please list all the individuals or groups who would disapprove or think 
that you should NOT get at least one HPV vaccination in the next 12 months”. We also 
asked: “Are there any other individuals or groups who come to mind when you think 
about you getting at least one HPV vaccination in the next 12 months?”. To elicit 
perceived behavioral control beliefs, we asked: “What factors, circumstances or settings 
might enable or make it easier for you to get at least one HPV vaccination in the next 12 
months?” and “What factors, circumstances, or settings would make it difficult or 
prevent you from getting at least one HPV vaccination in the next 12 months?” To make 
sure we did not miss any salient beliefs, we concluded the survey by asking: “Is there 
anything else that you associate with you getting at least one HPV vaccination in the next 
12 months?” 
Analytic Approach. Qualitative data from these surveys was analyzed using a 
content analysis approach. Consistent with this approach, emergent coding (Lindlof & 
Taylor, 2011) and constant comparative (Strauss & Corbin, 1990) methods were used to 
identify themes within each type of belief domain (behavioral, normative, and control). 
These methods allow themes to be identified inductively through constant comparison of 
concepts until saturation is reached. Unlike Robbins and Niederdeppe (2015), who 
defined themes as recurring belief sets held by more than half of the respondents, we used 
saturation to define our themes. According to Strauss & Corbin (1990), saturation is 
reached when no new themes emerge from the data. Salient beliefs in each domain are 
reported below.  
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Results 
Of the 32 participants, 19 were male and 11 were female, and the mean age was 
20.06 years. Participants were not particularly religious (M = 2.46, SD = 0.96) and mostly 
Caucasian (61.3%). Additional demographic data are provided in Table 1.  
Table 1  
Demographic Characteristics of Belief Elicitation Participants 
Characteristic Frequency Percent 
Sex    
     Male 19 63.3% 
     Female 11 36.7% 
Age    
     18 3 9.4% 
     19 14 43.8% 
     20 8 25% 
     21 2 6.3% 
     22 2 6.3% 
     23 0 0% 
     24 1 3.1% 
     25 1 3.1% 
     26 1 3.1% 
Race    
     Latino/Hispanic 1 3.1% 
     Black/African American 0 0% 
     Asian/Asian American 9 29% 
     White/Caucasian 19 61.3% 
     Native American 0 0% 
     Other 2 6.5% 
LGBT    
     Yes 3 9.7% 
     No 28 90.3% 
HPV Vaccinations    
     0 13 41.9% 
     1 5 16.1% 
     2 4 12.9% 
     3 0 0% 
     I don’t know 9 29.0% 
NOTE: N = 30-32 due to missing data 
 In Research Question 1, we asked: “Which behavioral, normative, and control 
beliefs regarding HPV vaccination are most salient within the college student 
population?”. Table 2 summarizes the most salient beliefs reported by participants. 
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Table 2 
Salient Behavioral, Normative, and Control Beliefs 
Behavioral 
(+) = positive, (-) = negative 
Normative 
(+) = approve, (-) = disapprove 
Perceived Behavioral Control 
(+) = enabler, (-) = barrier 
Prevent diseases like HPV/cervical 
cancer (+) 
Family (+) and (-) 
Peers (+) 
Anonymity (+) 
Availability/Accessibility (+) 
Protect my health (+) 
Protect the health of my partner(s) 
(+) 
Friends (+) 
Partners (+) 
Coworkers/Colleagues (+) 
Vaccine Knowledge (+) 
Physician Recommendation (+) 
Time (-) 
Peace of mind (+) 
Sore arm (-) 
Professors (+) 
Religious Groups (-) 
Cost (-) 
Embarrassment (-) 
Worry about side effects (-) Political Conservatives (-)  
Judgment (-)   
Sexual promiscuity (-)   
Vaccine cost (-)   
Appointment scheduling (-)   
 
 Salient behavioral beliefs included both positive and negative aspects of getting at 
least one HPV vaccination in the next twelve months (Table 2). Participants noted that 
getting the vaccine would prevent disease and protect their health. As one participant 
noted, “It [the vaccine] would keep me safe from cervical cancer and other diseases 
caused by HPV.” Participants also expressed the importance of protecting others by 
getting vaccinated. As one participant stated, “I could protect my sexual partners [by 
getting vaccinated].” Peace of mind also emerged as one of the most salient positive 
aspects of getting an HPV vaccination. Participants explained that getting vaccinated 
would help them be “worry free about this disease” and would allow them “peace of 
mind” due to the “security of not being susceptible to HPV.” Despite holding many 
positive beliefs about HPV vaccination, participants also held some negative beliefs. 
Most of the negative beliefs surrounding HPV vaccination had to do with the vaccine 
itself, such as fear of pain, fear of side effects, and fear of needles. Many participants 
expressed worry that their “arm would be sore” and that the vaccine would “potentially 
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cause some other health issues” or have “some negative side effects [such as] fainting, 
headaches, or dizziness.” Other participants voiced concern regarding the cost of the 
vaccine and how much time it would take to get one. One participant noted that “the 
vaccination costs a lot of money” and they were “not sure if health insurance will cover 
it.” Another participant noted, “It takes time to schedule an appointment.” And lastly, 
participants worried about parental and social disapproval, as well as increased sexual 
promiscuity following vaccination.  
 Salient normative beliefs included beliefs about those who would approve or 
disapprove of participants getting an HPV vaccination. Most participants mentioned that 
their families would approve of them getting an HPV vaccination, though for coding 
purposes, the family category included siblings, parents, grandparents, and extended 
family. Most participants also noted that their peers, friends, and partners would approve 
of their getting vaccinated. Though not mentioned as often as family and friends, 
coworkers/colleagues and professors were named as those who would approve of 
vaccination. Interestingly enough, parents were listed most often under the “who would 
disapprove” survey question. Some participants thought their grandparents or members of 
older generations would disapprove of their getting vaccinated. Though only mentioned 
occasionally, it is important to note that some participants felt certain religious groups 
and political conservatives would disapprove of their getting vaccinated. 
 Salient control beliefs included beliefs about factors would make it easier and 
factors that would make it more difficult to get at least one HPV vaccination in the next 
year. Factors that would enable participants to get vaccinated were anonymity (“Having it 
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[the vaccination] be private [and] not allowing my parents to find out”), access to 
convenient locations that offered free vaccines (“If there were more places to get the 
vaccination…multiple places on campus would help since I only know of Boynton on the 
Minneapolis campus”), knowledge about HPV and the vaccine (“More knowledge on 
what is in the vaccine and how it works”), and physician recommendation (“Have a 
doctor to tell me to have it [the vaccination] done when I am in for a checkup”). On the 
other hand, participants believed factors such as time, cost, and embarrassment would 
make it difficult or prevent them from getting an HPV vaccination. Some participants 
mentioned specific time constraints that would prevent them from obtaining the vaccine 
(“Credit load, juggling assignments, [and] going home for the summer”), and others were 
more general (“Just fitting it [the vaccination appointment] into my schedule would be 
the hardest part”). Other participants voiced concern regarding the vaccine being “costly” 
and that they were “unaware of insurance coverage.”   
Discussion 
 Results indicate participants believe that getting at least one HPV vaccination in 
the next twelve months will protect their health, with most specifically mentioning HPV 
and cervical cancer. Interestingly enough, none of the participants (male or female) 
mentioned protection from any of the other HPV-related cancers. This could be due to the 
fact that the vaccine has been branded and marketed as preventing cervical cancer and 
HPV, not as preventing anal, penile, and throat cancers. Not only did participants believe 
the vaccine would help protect themselves, they also seemed concerned about protecting 
their current and future sexual partners and believed getting vaccinated would also help 
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them do that. Several participants mentioned casual sex and the “hookup culture” as 
important reasons to protect themselves and others through vaccination. Though “peace 
of mind” was mentioned by several participants as a reason to get a vaccination in the 
next twelve months, only one acknowledged that the vaccine doesn’t protect against all 
types of HPV, nor is it 100% effective. Negative beliefs about obtaining the vaccine 
indicated that participants did not fully trust its safety. Almost all participants believed 
time and cost were barriers to vaccination, suggesting they are unaware that Boynton 
Health Services on campus offers HPV vaccinations and most health insurance 
companies cover the cost. 
 Results also indicated participants believe their friends and family are generally 
supportive of vaccination and would approve of them getting a vaccination in the next 
year. Parents were believed to be supportive by some participants and not supportive by 
others, but were frequently mentioned in both categories. This fits with previous research 
that suggests one’s social networks are hugely influential when it comes to health and 
HPV vaccination decisions. Many participants felt more comfortable with the idea of 
getting a vaccination in the next year if it was anonymous or if their parents would not 
find out. This could be because many participants mentioned embarrassment as a barrier 
to vaccination and perhaps this is why they would want to be vaccinated anonymously.  
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Study 2: Reasoned Action Survey 
 
 Phase two of our analysis involves creating a reasoned action survey using the 
belief elicitation results from above, using the second survey to gather quantitative data 
from another college student sample, and then analyzing it and using the results to answer 
RQ2. 
Methods 
 
 Following Yzer’s (2012a) process for applying the Reasoned Action Approach to 
health message design, qualitative belief elicitation survey data were used to identify 
salient beliefs that were then included in a reasoned action survey (Fishbein and Ajzen, 
2010). That is, quantitative, closed-ended reasoned action questions were formulated 
based on the salient belief data obtained from the belief elicitation survey. As with the 
Belief Elicitation study above, to maintain eligibility, participants could not have had 
more than two lifetime HPV vaccinations and had to be age 18 through 26.  
 Participants and Procedure. The University of Minnesota’s School of Journalism 
and Mass Communication’s Research Subject Pool was used to recruit participants (see 
the belief elicitation study methods section for details).  
Institutional Review Board approval for this study was received on April 9th, 2015 
and data were collected from participants (N = 226) between April 27th and May 3rd, 
2015. In order to be eligibile for this study, respondents could not have participated in the 
Belief Elicitation study, could not have more than 2 lifetime HPV vaccinations, and had 
to be age 18 through 26. After excluding participants who did not answer any questions 
beyond consent (n = 3), participants who did not answer any questions beyond sexual 
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history (n = 2), and participants who had already received all three HPV vaccinations in 
their lifetime (n = 22), the analytic sample contained data from 199 unique, qualified 
participants. 
Measures. The survey consisted of two eligibility questions (age and number of 
HPV vaccinations received), three demographic questions, three sexual history questions, 
a religiosity scale, two direct measures of intention, twelve behavioral belief questions, 
five direct measures of instrumental attitude, three direct measures of experiential 
attitude, two direct measures of perceived behavioral control - autonomy, one direct 
measure of perceived behavioral control – capacity, one direct measure of injunctive 
norms, one direct measure of descriptive norms, eight normative belief questions, and 
nine perceived behavioral control belief questions (See Appendix B).  
Once participants consented to participate in the survey, we asked a set of 
questions to determine participant eligibility: “How many HPV vaccination have you 
received?” and “What is your age?”. Those whose responses to the vaccination eligibility 
question were 0, 1, 2, or “I don’t know” were included in the analytic sample.  Next, we 
defined HPV and then outlined the CDC’s vaccination recommendations for men and 
women through age 26. We then asked the same set of demographic questions found in 
the belief elicitation study: “What is your sex?” (male/female), “Which of these groups 
best describes your racial or ethnic background?” (Latino/Hispanic, Black/African 
American, Asian/Asian American, White/Caucasian, Native American, Other), and “Do 
you identify as LGBT?” (yes/no). Next, we asked a series of sexual history questions: 
“Have you ever had sexual intercourse?” (yes/no), “Have you ever engaged in oral sex?” 
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(yes/no), and “Have you ever been diagnosed with HPV?” (yes, no, I don’t know). To 
assess religiosity, we used the Abbreviated Santa Clara Strength of Religious Faith 
Questionnaire (Plante, Vallaeys, Sherman, & Wallston, 2002), as described in the belief 
elicitation study.  
We then asked participants a series of closed-ended HPV vaccination-related 
questions. To directly measure intention to get vaccinated, we asked, “How likely is it 
that you will get at least one HPV vaccination in the next twelve months?” (7-point 
semantic differential scale where 1 = definitely will not and 7 = definitely will) and had 
them respond to the following statement: “I intend to get at least one HPV vaccination in 
the next twelve months” (7-point semantic differential scale where 1 = very unlikely and 
7 = very likely). To directly measure instrumental attitude, experiential attitude, and 
perceived behavioral control – autonomy we asked participants to respond to: 
“My getting at least one HPV vaccination in the next twelve months would be” with 11 
7-point semantic differential scales2: 
1. Extremely bad – Extremely good 
2. Extremely foolish – Extremely wise 
3. Extremely negative – Extremely positive 
4. Extremely harmful – Extremely beneficial 
5. Extremely unnecessary – Extremely necessary 
6. Extremely unenjoyable – Extremely enjoyable 
7. Extremely stressful – Extremely relaxing 
8. Extremely unpleasant – Extremely pleasant 
9. Extremely difficult – Extremely easy3 
10. Not under my control – Under my control 
11. Not up to me – Up to me 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 Numbers 1-5 measure instrumental attitude, 6-8 measure experiential attitude, 9 arguably measures either experiential 
attitude or perceived behavioral control – autonomy, and 10 and 11 measure perceived behavioral control – autonomy. 
3 There is some debate regarding the “difficult—easy” semantic differential and whether or not it measures attitude or 
perceived behavioral control. Because of this debate, it has been dropped from analysis. 
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To directly measure perceived behavioral control – capacity, we asked: “There can be a 
variety of obstacles to your getting at least one HPV vaccination in the next twelve 
months. Even in the face of such obstacles, how sure are you that if you really wanted to 
you can get at least one HPV vaccination in the next twelve months?” Participants 
responded on a 7-point semantic differential scale: completely sure I cannot – completely 
sure I can. To directly measure descriptive norms, we asked: “How many of the 
people who are most important to you do you think had at least one HPV vaccination in 
the last twelve months?” and had participants respond with “none,” “a few”, “some”, 
“most”, or “all.”  And finally, to directly measure injunctive norms, we asked: “How do 
you think most people important to you would feel about you getting at least one HPV 
vaccination in the next twelve months?”, and had participants respond on a 7-point 
semantic differential scale: strongly approve – strongly disapprove. 
To assess behavioral beliefs, we asked: “How likely is it that the following would 
happen to you if you got at least one HPV vaccination in the next twelve months?” We 
then listed the following beliefs gleaned from the Belief Elicitation study and asked 
participants to rate them on a 5-point semantic differential scale (where 1 = very unlikely 
and 5 = very likely): “Prevent HPV, feel judged, protect my health, worry less about 
HPV, protect my partner/future partner’s health, spend a lot of money on the vaccine, feel 
safer, be more sexually active, please my parents, have a sore arm, worry about the side 
effects, and spend a lot of time at the doctor.”  
To assess normative beliefs, we asked: “How do you think the following 
people would feel about you getting at least one HPV vaccination in the next twelve 
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months?” and listed “close friends, parents, grandparents, siblings, my partner(s)/future 
partner(s), professors, coworkers/colleagues, and my doctor.” Participants responded on a 
7-point semantic differential scale: strongly disapprove (= 1?) – strongly approve (= 7?). 
To assess control beliefs, we asked: “How sure are you that you can get at least 
one HPV vaccination in the next twelve months if you really wanted to, if:” and listed a 
number of obstacles: “you do not have health insurance, it takes time to schedule doctors 
appointments, the vaccine hurts, you are afraid of vaccines, you are busy, the vaccine has 
side effects, your parents would find out, you go home for the summer, the vaccine is not 
free.” Participants responded on a 5-point semantic differential scale: not at all sure I can 
(= 1) – completely sure I can (= 5). 
Analytic Approach. The Reasoned Action approach allows us to begin the 
process of identifying promising message strategies by helping us distinguish which 
proximal determinants are most strongly correlated with vaccination intention. Thus the 
statistical software package SPSS was used to analyze quantitative data. 
Attitudes, norms, perceived behavioral control, and intention were each measured 
directly with multiple questions. First, as discussed above, intention was directly 
measured with two questions: “How likely is it that you will get at least one HPV 
vaccination in the next twelve months” and “I intend to get at least one HPV vaccination 
in the next twelve months”. Responses from these two questions were first correlated (r = 
0.923) to ensure they were highly related and then combined to create a mean intention 
score (1-7, where 1 = very unlikely/definitely will not and 7 = very likely/definitely will). 
Second, the five measures of instrumental attitude (α = 0.925) and the three measures of 
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experiential attitude (α = 0.834) were correlated to ensure they were highly related and 
then combined to create mean scores for each. Third, the two measures for perceived 
behavioral control – autonomy were correlated (r = 0.816) to ensure they were highly 
related prior to being averaged into a mean score. And finally, additional mean scores 
were generated for the one direct measure of perceived behavioral control – capacity, the 
one direct measure of injunctive norms, and the one direct measure of descriptive norms 
(Table 4) and then stratified by sex (Table 5). These six mean scores were first correlated 
with each other (Table 6) and then, through multivariable linear regression analyses to 
assess the adjusted strength of association, with vaccination intention (Table 7 and Figure 
1).  
Results 
As Table 3 below indicates, participants were fairly evenly divided among males 
and females and a majority had engaged in sexual intercourse and/or oral sex, though all 
reported never (98%) or not knowingly (2%) being diagnosed with HPV. Participants 
were mostly Caucasian (74.9%) and between the ages of 19 and 22. Of the 199 
participants, only 6.5% identified as LGBT and the overall mean religiosity was low (M = 
2.07, SD = 0.86), making LGBT and religiosity subanalyses difficult. This will be 
discussed in further detail in the Conclusion and Future Research section below. 
Importantly, 78.9% of participants answered that they had less than three HPV 
vaccinations (21.1% did not know how many vaccinations they had received). 
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Table 3 
 
Demographic Characteristics of Reasoned Action Participants 
 Frequency Percent 
Sex    
     Male 92 46.2% 
     Female 107 53.8% 
Age   
     18 18 9% 
     19 63 31.7% 
     20 58 29.1% 
     21 27 13.6% 
     22 20 10.1% 
     23 4 2% 
     24 4 2% 
     25 2 1% 
     26 3 1.5% 
Race    
     Latino/Hispanic 3 1.5% 
     Black/African American 1 0.5% 
     Asian/Asian American 42 21.1% 
     White/Caucasian 149 74.9% 
     Native American 1 0.5% 
     Other 3 1.5% 
LGBT   
     Yes 13 6.5% 
     No 186 93.5% 
Sexual Intercourse    
     Yes 125 63.1% 
     No 73 36.9% 
Oral Sex    
     Yes 128 64.3% 
     No 71 35.7% 
HPV Diagnosis    
     Yes 0 0% 
     No 195 98% 
     I don’t know 4 2% 
HPV Vaccinations    
     0 63 31.7% 
     1 48 24.1% 
     2 46 23.1% 
     3 0 0% 
     I don’t know 42 21.1% 
NOTE: N = 198-199 due to missing data 
 
 As Table 4 indicates, participants had fairly favorable instrumental attitudes (M = 
5.05), but lower experiential attitudes (M = 3.64). This suggests that although 
participants think that getting an HPV vaccination would be a smart thing to do, it would 
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not necessarily be pleasant or enjoyable. Interestingly, participants reported that although 
most of the people closest to them had not received an HPV vaccination (M = 2.31), they 
felt these people would be supportive of them getting vaccinated (M = 5.21). In addition, 
participants reported feeling confident in both aspects of perceived behavioral control (M 
= 5.62 and 5.49) regarding HPV vaccination. That is, they felt confident in their abilities 
to get the vaccination, and they felt getting the vaccination was ultimately up to them. 
Despite having favorable attitudes, social support, and high perceived behavioral control 
regarding vaccination, intention to get at least one HPV vaccination in the next twelve 
months remained low (M = 3.77).   
Table 4 
Proximal Determinant and Intention Means and SDs 
Construct Mean SD 
Instrumental Attitude 5.05 1.18 
Experiential Attitude 3.64 1.03 
Descriptive Norms 2.31 0.95 
Injunctive Norms 5.21 1.29 
Perceived Behavioral Control - Autonomy 5.62 1.27 
Perceived Behavioral Control - Capacity 5.49 1.46 
Intention 3.77 1.87 
 
 As Table 5 indicates, proximal determinant means varied by the sex of the 
participant. With the exception of experiential attitudes, females tended to have greater 
intentions, more favorable attitudes, higher norms, and greater perceived behavioral 
control than males.   
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Table 5 
Stratified Proximal Determinant and Intention Means and SDs 
Construct Sex Mean SD 
Instrumental Attitude Male 4.737 0.120 
 Female 5.315 0.111 
Experiential Attitude Male 3.679 0.107 
 Female 3.616 0.100 
Descriptive Norms Male 2.152 0.098 
 Female 2.453 0.092 
Injunctive Norms Male 4.978 0.133 
 Female 5.415 0.124 
Perceived Behavioral Control - Autonomy Male 5.484 0.132 
 Female 5.726 0.123 
Perceived Behavioral Control - Capacity Male 5.217 0.150 
 Female 5.708 0.140 
Intention Male 3.380 0.191 
 Female 4.137 0.178 
 
  In Research Question 2, we asked: Are attitudes, perceived norms, or perceived 
behavioral control regarding vaccination most strongly associated with intention to get 
vaccinated against HPV? To answer this, we must see how the proximal determinants are 
correlated with each other and intention (Table 6), and then examine each proximal 
determinant’s adjusted association with intention (Table 7 and Figure 1). 
T able 5 indicates that one of the two dimensions of attitude (instrumental, r = 
0.553) was moderately correlated with intention to get vaccinated. Although both 
dimensions of subjective norm were moderately correlated with intention, injunctive 
norms were more so (r = 0.503). And again, even though both dimensions of perceived 
behavioral control were correlated with intention, the magnitude of the capacity 
dimension-intention correlation was greater  (r = 0.348).   
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Table 6 
 
Proximal Determinant Correlations 
NOTE: N = 198-199, *significant at p<0.001, **significant at p=0.001, ***significant at p=0.05 
Consistent with the correlation analysis (Table 6), results from the regression 
analysis (Table 7) show a strong, positive relationship between instrumental attitude and 
intention to get vaccinated (b = 0.631). Though not quite as strong, results indicate a 
moderate, positive relationship between descriptive norms and intention to get vaccinated 
(b = 0.396).  Figure 1 shows the relative association of each determinant vis-à-vis 
intention. 
Table 7 
 
Regression Analysis 
 
 
 
 
 
 
 
 
 
NOTE: r2 = 0.391 N = 199 
 
 
 
 
 
 1 2 3 4 5 6 7 
1. Instrumental Attitude 1.000       
2. Experiential Attitude 0.393* 1.000      
3. Descriptive Norms 0.271* 0.139*** 1.000     
4. Injunctive Norms 0.722* 0.255* 0.325* 1.000    
5. Perceived Behavioral 
Control – Autonomy 
0.410* 0.058 0.033 0.361* 1.000   
6. Perceived Behavioral 
Control – Capacity 
0.424* -0.056 0.240** 0.510* 0.378* 1.00  
7. Intention 0.553* 0.225** 0.379* 0.503* 0.142*** 0.348* 1.000 
Explanatory Variables b  SEb Beta P 
Intercept 1.238 (0.661)  0.063 
Instrumental Attitude 0.631  (0.661) 0.400 0.000 
Experiential Attitude 0.028  (0.141) 0.015 0.810 
Descriptive Norms 0.396  (0.116) 0.203 0.001 
Injunctive Norms 0.181  (0.126) 0.126 0.153 
Perceived Behavioral Control - Autonomy 0.171  (0.095) -0.117 0.072 
Perceived Behavioral Control - Capacity 0.153  (0.090) 0.120 0.091 
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Figure 1 
 
Standardized Regression Coefficients 
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The regression model accounted for about 39% of the variance in vaccination 
intention, with instrumental attitude and descriptive norms being the most predictive. 
This is important because if these two constructs are responsible for a majority of the 
variance in intention to get vaccinated, their underlying beliefs should be considered as 
potential targets for a pro-vaccination campaign (see the future research section for 
discussion).  
Discussion 
 
 Results suggest that there is room to improve intention to get vaccinated (M = 
3.77). Among this sample of college students, instrumental attitude is the greatest 
predictor of intention to get at least one HPV vaccination in the next twelve months. This 
indicates participants who believed vaccination was good, wise, positive, beneficial, and 
Instrumental	  Attitude	  
Experiential	  Attitude	  
Descriptive	  Norms	  
Injunctive	  Norms	  
Perceived	  Behavioral	  Control	  (Autonomy)	  
Perceived	  Behavioral	  Control	  (Capacity)	  
Intention	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necessary were more likely to intend to get one in the next twelve months. Another strong 
predictor of vaccination intention was descriptive norms. This indicates participants who 
believed others in their social networks were getting vaccinated were more likely to 
intend to get at least one HPV vaccination in the next twelve months.  
Interestingly enough, both the autonomy and capacity aspects of perceived 
behavioral control were the least predictive of intention to get vaccinated. Perhaps 
counter-intuitively, those who thought getting the vaccination was up to them were less 
likely to intend to get vaccinated than those who did not. That is, feeling like they had 
more control over their action made them less likely to intend to get vaccinated. This 
could possibly be the result of participants feeling like they did not need the vaccine or 
the vaccine wasn’t for them even though they felt the decision to get one was theirs. 
Though the participants were not the same in both studies, evidence of this was also 
found in the belief elicitation.  
Lastly, the stratified proximal determinant means suggest that female participants 
may have greater intentions to get vaccinated, more favorable instrumental attitudes, 
believe more of their social network has been vaccinated, believe their social networks 
would support them more, and feel like they are capable of getting the vaccination and it 
is ultimately up to them. This may not be surprising, given that the vaccination did not 
get gender-neutral approval until 2009. It is possible that since it was only marketed 
toward women initially, that it is still seen as a “women’s vaccine.” This could explain 
why intention to get the vaccine among males is lagging. It is important to point out, 
however, that since significance testing was not part of the analysis, the differences 
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observed in the stratified analysis might not be statistically significant. Future research 
could explore this possibility. 
 
Conclusion and Further Research 
Conclusions derived from Reasoned Action studies 
 This mixed-method project explored both distal (salient beliefs) and proximal 
(attitudes, subjective norms, and perceived behavioral control) determinants of HPV 
vaccination intention in a college student population sample.  
The qualitative belief elicitation survey allowed us to determine the most salient 
behavioral, normative, and control beliefs in this college student sample. Positive salient 
behavioral beliefs regarding vaccination included beliefs about protecting one’s own 
health, as well as the health of one’s partners and future partners. Participants also felt 
like getting the vaccination would allow them peace of mind regarding HPV and cervical 
cancer. Interestingly, participants made no mention of other types of HPV-related cancer, 
nor did they express concern that the vaccine only protects against two types of HPV. 
This could be due to lack of knowledge or the fact that the vaccine has been consistently 
marketed as an anti cervical cancer vaccine. 
 Negative salient behavioral beliefs included fear of the vaccination (pain and side 
effects), the cost of the vaccination, and the time it takes to schedule an appointment. 
Though a few participants mentioned fear of increased sexual activity post-vaccination, 
this was not a commonly held belief. Also, participants who mentioned this as a fear did 
not express that they were afraid for themselves, but rather, it sounded like they were 
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afraid it would increase sexual activity in others. It is possible that this is due to the “third 
person effect” – the belief that the vaccine will negatively affect other people, “but not 
me.”     
Positive salient normative beliefs included feeling as though friends, peers, 
coworkers/colleagues, professors, and partners supported vaccination. Though many 
participants reported feeling supported by their families (mostly parents) as well, many 
did not. This appeared again in the perceived behavioral control section of the survey – 
participants felt more comfortable with the idea of getting vaccinated if their parents 
would not find out. Perhaps participants were afraid their parents would think they were 
sexually active and/or promiscuous if they got vaccinated. Some participants also 
reported feeling like religious groups and political conservatives would not support their 
choice to get vaccinated. It is important to note here that participants had a relatively low 
mean religiosity score, suggesting most of them did not rely heavily on their faith in their 
daily lives.  
Enablers to vaccination included the vaccine being accessible, widely available, 
and anonymous. Many participants also felt having more knowledge on HPV and the 
vaccine and a recommendation from a physician would encourage them to get a 
vaccination. Barriers to vaccination included the time it takes to get a vaccination, the 
cost of the vaccination if it were not covered by health insurance, and embarrassment. 
Though most participants reported feeling supported in their vaccination decision by 
those closest to them, most were still concerned about embarrassment (peers) and 
anonymity (parents). Perhaps this is because participants associated the vaccine with 
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sexual activity and felt that only those who are sexually active should get one. By getting 
vaccinated, they would be broadcasting their sexual activity to their social networks, 
which many found embarrassing. 
 The quantitative reasoned action survey built on the belief elicitation survey, 
allowing us to determine which proximal determinants were most strongly associated 
with intention to get at least one HPV vaccination in the next twelve months. Regression 
analysis shows that instrumental attitudes and descriptive norms are the strongest 
predictors of intention to get vaccinated. The more participants believed that getting the 
vaccination was wise and the more people in their social networks they believed had 
already been vaccinated, the more likely they were to intend to get vaccinated 
themselves. Perhaps this is a product of the college student sample. Being in college, one 
relies heavily on their cognitive abilities and attempts to enhance their critical thinking 
skills. Relying on rationality (i.e. “evidence shows the vaccine is a good idea”) as the 
basis for decision-making makes sense in this population.  
Now that we have identified instrumental attitude through the Reasoned Action 
Approach as the strongest proximal determinant of intention to get at least one HPV 
vaccination in the next twelve months, the final step in the process of identifying 
promising message strategies will be to turn to Hornik and Woolf’s (1999) extension of 
the Reasoned Action approach. 
Future directions: Identifying promising message strategies  
 
Hornik and Woolf’s (1999) extension of the Reasoned Action Approach is 
instrumental in helping us identify which of the underlying beliefs (not just proximal 
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determinants) are most correlated with intention (RQ3) and whether or not these beliefs 
could be influenced by a strategic message (RQ4).   
As Table 8 indicates, the beliefs most strongly associated with intention to get 
vaccinated are “I will protect my health” (r = 0.379), and feeling like “close friends” (r = 
0.380) and “my partner(s)/future partner(s)” (r = 0.394) support vaccination.   
Table 8 
 
Underlying Belief Correlations with Intention 
Belief N r 
How likely is it that the following would happen to you if you got at least one HPV vaccination in the 
next twelve months? I would: 
I will prevent HPV 199 0.258* 
I will feel judged 199 -0.180*** 
I will protect my health 199 0.379* 
I will worry less about HPV 199 0.278* 
I will protect my current/future partner’s health 198 0.349* 
I will spend a lot of money on the vaccine 199 -0.227** 
I will feel safer 199 0.335* 
I will be more sexually active 199 0.096 
I will please my parents 199 0.267* 
I will have a sore arm 199 0.065 
I will worry about the side effects of the vaccine 199 -0.139 
I will spend a lot of time at the doctor 199 -0.221*** 
How do you think the following people would feel about you getting at least one HPV vaccination in the 
next twelve months? They would: (strongly disapprove(1) to strongly approve(7) 
Close friends 199 0.380* 
Parents 199 0.339* 
Grandparents 198 0.230** 
Siblings 198 0.289* 
My partner(s) / Future partner(s) 199 0.394* 
Professors 198 0.163*** 
Coworkers / Colleagues 199 0.167*** 
My doctor 199 0.340* 
How sure are you that you can get at least one HPV vaccination in the next twelve months if you really 
wanted to, if: 
You do not have health insurance 199 0.106 
It takes time to schedule doctors appointments 199 0.251* 
The vaccine hurts 199 0.152*** 
You are afraid of vaccines 197 0.201*** 
You are busy 197 0.185*** 
The vaccine has side effects 198 0.208*** 
Your parents would find out 199 0.239** 
You go home for the summer 199 0.165*** 
The vaccine is not free 198 0.181*** 
NOTE: *significant at p<0.001, **significant at p=0.001, ***significant at p=0.05 
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In order to answer RQ4, we would next need to determine if any of these beliefs 
are moveable and if they can be influenced by a strategic message. To determine if the 
beliefs are moveable, we would need to calculate the percentages of participants who 
hold and do not hold the belief. For example, we would calculate the percentage of 
participants who believe they would be protecting their health by getting a vaccination 
and those who do not believe so. If there is a large percentage of participants who do not 
believe they would be protecting their health by getting vaccinated, and we think we can 
convince them otherwise with a strategic message, this belief would be a good candidate 
for targeting in a pro-vaccination campaign. These analyses will be conducted moving 
forward. 
Another important consideration when targeting beliefs for a strategic message 
campaign is whether or not highly correlated beliefs differ among participants (Parvanta 
et al., 2013). As discussed in the Literature Review, studies have suggested that HPV 
vaccination beliefs could differ along gender, religiosity, and LGBT lines. Also, as we 
saw in the reasoned action analysis, proximal determinants may differ along gender lines. 
Therefore, it would be crucial to conduct these subanalyses to determine if different 
messages need to be created for different segments of the target population (i.e. different 
messages for men and women). Future research would include a larger, or perhaps 
targeted, LGBT sample so that the results could be contrasted with the results from this 
study to see if beliefs and/or proximal determinants differed at all in this high-risk 
population.  
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Limitations 
 Though this study can be used to inform message strategies regarding HPV 
vaccination in college student populations, it has some limitations that are worth noting. 
First, the constant comparative method used in the belief elicitation study often utilizes 
more than one coder to guard against idiosyncratic coding. In future studies, I would 
employ other coders so that this could be achieved. Also, with both the belief elicitation 
and the reasoned action surveys, sample sizes were small, especially among 
subpopulations of interest (high religiosity, LGBT, and certain racial categories). In order 
to make the results from both surveys more generalizable, I would conduct this study 
again with a larger and, if possible, more representative sample.    
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Appendix A 
 
Belief Elicitation Survey 
 
INFORMATION SHEET FOR RESEARCH CONSENT      
 
You are invited to be in a research study of college students' human papillomavirus 
(HPV) vaccination beliefs, attitudes, and experiences. You were selected as a possible 
participant because you have signed up for the School of Journalism and Mass 
Communication subject pool and/or are enrolled in undergraduate courses in the SJMC. 
We ask that you read this form and ask any questions you may have before agreeing to be 
in the study.   
 
Procedures: If you agree to participate in this study, we will ask you a series of 
questions about yourself and perceptions of your getting at least one HPV vaccination in 
the next 12 months. The survey should take approximately 15-30 minutes to complete.      
 
Confidentiality: All information gathered will be anonymous. In any sort of report we 
might publish, we will not include any information that will make it possible to identify 
you. Research records will be stored securely and only researchers will have access to the 
records. You will not be linked to your responses in any way; it will not be possible to 
identify you based on your responses to this survey.  
 
Voluntary Nature of the Study: Participation in this study is voluntary. Your decision 
whether or not to participate will not affect your current or future relations with the 
University of Minnesota or the School of Journalism and Mass Communication. If you 
decide to participate, you are free to not answer any question or withdraw at any time 
without affecting those relationships. 
 
Risks and Benefits of being in the Study: The study has one risk: we will be asking a 
few sensitive questions that might cause you to feel embarrassed or uncomfortable. 
Though this risk is possible, your answers will not be traceable back to you and you do 
not have to answer questions you feel uncomfortable answering. By participating in this 
study you will help us understand how college students think about HPV vaccination.  
 
Contacts and Questions: Please make sure you understand the risks and benefits of 
participation in your own words. The researcher conducting this study is Lauren Gray. If 
you have questions, you are encouraged to contact her before agreeing to participate at 
300 Murphy Hall, the University of Minnesota-Twin Cities, (612)625-9824, 
grayx231@umn.edu. The advisor is Dr. Rebekah Nagler, who can be reached at 
(612)625-9388, nagle026@umn.edu. 
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If you have any questions or concerns regarding this study and would like to talk to 
someone other than the researcher(s), you are encouraged to contact the Research 
Subjects’ Advocate Line, D528 Mayo, 420 Delaware St. Southeast, Minneapolis, 
Minnesota 55455; (612)625-1650.  I have read, understood, and printed a copy of, the 
above consent form and desire of my own free will to participate in this study. 
m Yes  
m No  
 
Thank you for agreeing to participate in this study about HPV vaccination beliefs. Human 
Papillomavirus is the most common sexually transmitted infection in the United States. 
Currently, there is a three-dose vaccine for men and women to protect against HPV 
infection. The Centers for Disease Control and Prevention recommends that young adults 
through age 26 get vaccinated against HPV. Remember that your answers will be strictly 
confidential, which means we will never connect them with your name in any way.  To 
protect your privacy, we ask that you refrain from typing anything in your responses that 
would make it possible to identify you. We hope that you will answer all of our 
questions.  However, if there are some that you do not want to answer, you may leave 
them blank. In this study, we will ask you some questions about yourself and how you 
feel about getting at least one Human Papillomavirus vaccination in the next 12 months.  
 
We first want to ask you some quick questions about yourself. 
 
Q1 What is your age? 
 
Q2 What is your sex? 
m Male  
m Female  
 
Q3 Which of these groups best describes your racial or ethnic background? 
m Latino/Hispanic  
m Black/African American  
m Asian/Asian American 
m White/Caucasian  
m Native American  
m Other  
 
Q4 If "other," please specify: 
 
Q5 Do you identify as LGBT? 
m Yes  
m No  
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Q6 Please answer the following questions about your religious faith using the scale 
below. Indicate the level of agreement (or disagreement) for each statement. 
 
    
The next series of questions are about getting at least one HPV vaccination.  There is a lot 
of talk these days about this subject and we still have a lot to learn about the actual 
experiences and attitudes of people your age. 
 
It is recommended that adolescents and young adults up to age 26 get a series of three 
vaccinations to protect against HPV. 
 
Q7 How many HPV vaccinations have you gotten in your lifetime?  Please mark the 
answer that best applies to you. 
 
m 0 
m 1 
m 2 
m 3 
m I don’t know 
 
 
 Strongly Disagree Disagree Agree 
Strongly     
Agree 
I pray daily. m  m  m  m  
I look to my faith as 
providing meaning and 
purpose in my life. m  m  m  m  
I consider myself active 
in my faith or church. m  m  m  m  
I enjoy being around 
others who share my 
faith m  m  m  m  
My faith impacts many 
of my decisions. m  m  m  m  
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The next series of questions are about your perceptions of your getting at least one HPV 
vaccination in the next 12 months.  Please write down everything that comes to mind. 
Q8 What do you see as the advantages of your getting at least one HPV vaccination in the 
next [1 month, 3 months, 12 months]? What are the good things that might happen if 
you would get at least one HPV vaccination in the next 12 months? 
 
Q9 What do you see as the disadvantages of your getting at least one HPV vaccination in 
the next [1 month, 3 months, 12 months]? What are the bad things that might happen if 
you would get at least one HPV vaccination in the next 12 months? 
 
Q10 Please list all the individuals or groups who would approve or think that you should 
get at least one HPV vaccination in the next [1 month, 3 months, 12 months]. 
 
Q11 Please list all the individuals or groups who would disapprove or think that you 
should not get at least one HPV vaccination in the next [1 month, 3 months, 12 
months]. 
 
Q12 Are there any other individuals or groups who come to mind when you think about 
your getting at least one HPV vaccination in the next [1 month, 3 months, 12 months]? 
 
Q13 What factors, circumstances or settings might enable or make it easier for you to get 
at least one HPV vaccination in the next [1 month, 3 months, 12 months]? 
 
Q14 What factors, circumstances, or settings would make it difficult or prevent you from 
getting at least one HPV vaccination in the next [1 month, 3 months, 12 months]? 
 
Q15 Is there anything else that you associate with your getting at least one HPV 
vaccination in the next [1 month, 3 months, 12 months]? 
 
 
END 
Thank you very much for your participation. 
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Appendix B 
 
Reasoned Action Survey 
 
INFORMATION SHEET FOR RESEARCH CONSENT      
 
You are invited to be in a research study of college students' human papillomavirus 
(HPV) vaccination beliefs, attitudes, and experiences. You were selected as a possible 
participant because you are between the ages of 18 and 26 and have signed up for 
the School of Journalism and Mass Communication subject pool and/or are enrolled in 
undergraduate courses in the SJMC. We ask that you read this form and ask any 
questions you may have before agreeing to be in the study.   
 
Procedures: If you agree to participate in this study, we will ask you a series of 
questions about yourself and perceptions of your getting at least one HPV vaccination in 
the next 12 months. The survey should take approximately 15-30 minutes to complete.      
 
Confidentiality: All information gathered will be anonymous. In any sort of report we 
might publish, we will not include any information that will make it possible to identify 
you. Research records will be stored securely and only researchers will have access to the 
records. You will not be linked to your responses in any way; it will not be possible to 
identify you based on your responses to this survey.  
 
Voluntary Nature of the Study: Participation in this study is voluntary. Your decision 
whether or not to participate will not affect your current or future relations with the 
University of Minnesota or the School of Journalism and Mass Communication. If you 
decide to participate, you are free to not answer any question or withdraw at any time 
without affecting those relationships. 
 
Risks and Benefits of being in the Study: The study has one risk: we will be asking a 
few sensitive questions that might cause you to feel embarrassed or uncomfortable. 
Though this risk is possible, your answers will not be traceable back to you and you do 
not have to answer questions you feel uncomfortable answering. By participating in this 
study you will help us understand how college students think about HPV vaccination.  
 
Compensation: You will be granted two extra credit points for participating in this 
study. You are still eligible for extra credit if you skip some questions or quit the survey 
early. 
 
Contacts and Questions: Please make sure you understand the risks and benefits of 
participation in your own words. The researcher conducting this study is Lauren Gray. If 
you have questions, you are encouraged to contact her before agreeing to participate at 
300 Murphy Hall, the University of Minnesota-Twin Cities, (612)625-9824, 
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grayx231@umn.edu. The advisor is Dr. Rebekah Nagler, who can be reached at 
(612)625-9388, nagle026@umn.edu. 
 If you have any questions or concerns regarding this study and would like to talk to 
someone other than the researcher(s), you are encouraged to contact the Research 
Subjects’ Advocate Line, D528 Mayo, 420 Delaware St. Southeast, Minneapolis, 
Minnesota 55455; (612)625-1650.  I have read, understood, and printed a copy of the 
above consent form, certify that I am between the ages of 18 and 26, and desire of my 
own free will to participate in this study. 
m Yes  
m No  
Thank you for agreeing to participate in this study about HPV vaccination. Human 
Papillomavirus is the most common sexually transmitted infection in the United States. 
Currently, there is a three-dose vaccine for men and women to protect against HPV 
infection. The Centers for Disease Control and Prevention recommends that young adults 
through age 26 get vaccinated against HPV. Remember that your answers will be strictly 
confidential, which means we will never connect them with your name in any way.  We 
hope that you will answer all of our questions.  However, if there are some that you do 
not want to answer, you may leave them blank. There are no correct or incorrect answers 
to the questions in this survey; it’s really your opinion that matters. Remember that your 
first responses are usually the most accurate. 
We would like to begin by asking you a little information about yourself. 
Q1 What is your age? 
Q2 What is your sex? 
m Male (1) 
m Female (2) 
Q3 Which of these groups best describes your racial or ethnic background? 
m Latino/Hispanic (1) 
m Black/African American (2) 
m Asian/Asian American (3) 
m White/Caucasian (4) 
m Native American (5) 
m Other (6) 
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Q4 If "other," please specify: 
Q5 Do you identify as LGBT? 
m Yes  
m No  
Q6 How many HPV vaccinations have you received? 
m 0 
m 1 
m 2 
m 3 
m I don't know 
Q7 Please answer the following questions about your religious faith using the scale 
below. Indicate the level of agreement (or disagreement) for each statement. 
Strongly 
Disagree 
Disagree Agree Strongly 
Agree 
I pray daily. m m m m 
I look to my faith as 
providing meaning and 
purpose in my life. 
m m m m 
I consider myself active 
in my faith or church. m m m m 
I enjoy being around 
others who share my 
faith. m m m m 
My faith impacts many 
of my decisions. m m m m 
Q8 Have you ever had sexual intercourse? 
m Yes (1) 
m No (2) 
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Q9 Have you ever engaged in oral sex? 
m Yes (1) 
m No (2) 
Q10 Have you ever been diagnosed with HPV? 
m Yes (1) 
m No (2) 
m I don't know (3) 
The next series of questions is about getting the HPV vaccination. There is a lot of talk 
these days about this subject and we still have a lot to learn about the actual experiences 
and attitudes of people your age. It is recommended that adolescents and young adults up 
to age 26 get a series of three vaccinations to protect against HPV. 
Q11 The next series of questions is about your perceptions of your getting at least one 
HPV vaccination in the next twelve months. 
Q12 How likely is it that you will get at least one HPV vaccination in the next twelve 
months? 
1 2 3 4 5 6 7 
I 
definitely
  will 
not 
m m m m m m m 
I 
definitely
  will 
Q13 I intend to get at least one HPV vaccination in the next twelve months. 
1 2 3 4 5 6 7 
Very 
unlikely m m m m m m m 
Very 
likely 
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Q14 How likely is it that the following would happen to you if you got at least one HPV 
vaccination in the next twelve months?  I would: 
Q15 My getting at least one HPV vaccination in the next twelve months would be:   
Very 
Unlikely
Unlikely Neither 
likely 
nor 
unlikely 
Likely Very 
Likely 
Be healthier  m m m m m 
Feel ashamed  m m m m m 
Be in pain  m m m m m 
Worry less about HPV m m m m m 
Feel more confident m m m m m 
Spend much time scheduling 
doctors appointments  m m m m m 
Spend a lot of money  m m m m m 
Be more sexually active  m m m m m 
Be safer m m m m m 
Lower my risk of getting HPV m m m m m 
Feel better  m m m m m 
1 2 3 4 5 6 7 
Extremely bad  m m m m m m m Extremely good 
Extremely foolish m m m m m m m Extremely wise 
Extremely negative m m m m m m m Extremely positive 
Extremely harmful  m m m m m m m Extremely beneficial 
Extremely unnecessary m  m  m  m  m  m  m  Extremely necessary 
Extremely unenjoyable  m  m  m  m  m  m  m  Extremely enjoyable 
Extremely stressful  m m m m m m m Extremely relaxing 
Extremely unpleasant m m m m m m m Extremely pleasant 
Extremely difficult m m m m m m m Extremely easy 
Not under my control m m m m m m m Under my control 
Not up to me  m m m m m m m Up to me 
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Q16 There can be a variety of obstacles to your getting at least one HPV vaccination in 
the next twelve months. Even in the face of such obstacles, how sure are you that if you 
really wanted to you can get at least one HPV vaccination in the next twelve months? 
1 2 3 4 5 6 7 
Completely  
sure I cannot m m m m m m m 
Completely 
sure I can 
Q17 How many of the people who are most important to you do you think had at least 
one HPV vaccination in the last twelve months? If you are not sure, make your best 
guess. 
m None  
m A few 
m Some 
m Most 
m All 
Q18 How do you think most people important to you would feel about you getting at 
least one HPV vaccination in the next twelve months? They would: 
Q19 How do you think your close friends would feel about you getting at least one HPV 
vaccination in the next twelve months? They would:  
Q20 How do you think your family would feel about you getting at least one HPV 
vaccination in the next twelve months? They would:  
1 2 3 4 5 6 7 
Strongly 
disapprove m m m m m m m 
Strongly 
approve 
1 2 3 4 5 6 7 
Strongly 
disapprove m m m m m m m 
Strongly 
approve 
1 2 3 4 5 6 7 
Strongly 
disapprove m m m m m m m 
Strongly 
approve 
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Q21 How do you think your doctor or other health care provider would feel about 
you getting at least one HPV vaccination in the next twelve months? They would: 
Q22 How do you think your classmates would feel about you getting at least one HPV 
vaccination in the next twelve months? They would: 
Q23 How sure are you that you can get at least one HPV vaccination in the next twelve 
months if you really wanted to, if: 
This concludes the survey.  Thank you for your participation! 
1 2 3 4 5 6 7 
Strongly 
disapprove m m m m m m m 
Strongly 
approve 
1 2 3 4 5 6 7 
Strongly 
disapprove m m m m m m m 
Strongly 
approve 
Not at all 
sure I can 
Not sure I 
can 
Neither 
sure or 
unsure I 
can 
Sure I can Completely
sure I 
can 
You do not have 
health insurance  m m m m m 
It takes time to 
schedule doctors 
appointments  
m m m m m 
The vaccine hurts m m m m m 
You are afraid of 
vaccines m m m m m 
You are busy m m m m m 
The vaccine has side 
effects  m m m m m 
Your doctor is at 
your hometown 
clinic  
m m m m m 
